Long-Term OL Study of [S,S]-RBX in Patients With Fibromyalgia

This study has been terminated.

( This study has been terminated early as the esreboxetine development program is being discontinued. There are no safety or efficacy concerns. )

Study NCT00607256 Information provided by Pfizer

First Received: January 23, 2008 Last Updated: March 17, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Fibromyalgia

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

[S,S]-reboxetine

Additional drug interventions recognized in this trial

Reboxetine

More general drug interventions related to this trial

Sponsors listed in this trial

Pfizer